You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.

Jump To Section:

Identification Taxonomy Ontology Physical properties Spectra Biological properties Concentrations Links References XML

Record Information

Version

5.0

Status

Detected and Quantified

Creation Date

2009-04-06 16:19:54 UTC

Update Date

2021-09-14 15:45:46 UTC

HMDB ID

HMDB0012141

Secondary Accession Numbers

HMDB12141

Metabolite Identification

Common Name

(R)-2,3-Dihydroxy-isovalerate

Description

(R) 2,3-Dihydroxy-isovalerate is an intermediate in valine, leucine and isoleucine biosynthesis. The pathway of valine biosynthesis is a four-step pathway that shares all of its steps with the parallel pathway of isoleucine biosynthesis. These entwined pathways are part of the superpathway of leucine, valine, and isoleucine biosynthesis , that generates not only isoleucine and valine, but also leucine. (R) 2,3-Dihydroxy-isovalerate is generated from 3-Hydroxy-3-methyl-2-oxobutanoic acid via the enzyme ketol-acid reductoisomerase (EC 1.1.1.86) then it is converted to 2-Oxoisovalerate via the dihydroxy-acid dehydratase (EC:4.2.1.9).

Structure

MOL 3D MOL SDF 3D SDF PDB 3D PDB SMILES InChI

View in JSmol View NMR Assignments View Stereo Labels

Synonyms

Value	Source
(R)-2,3-Dihydroxy-isovaleric acid	ChEBI
(2R)-2,3-Dihydroxy-3-methylbutanoate	Kegg
(2R)-2,3-Dihydroxy-3-methylbutanoic acid	Generator
(R)-2,3-Dihydroxy-3-methylbutanoate	HMDB
(R)-2,3-Dihydroxy-3-methylbutanoic acid	HMDB
(R)-(-)-alpha,beta-Dihydroxyisovaleric acid	HMDB
(R)-(-)-α,β-Dihydroxyisovaleric acid	HMDB
(R)-2,3-Dihydroxy-isovalerate	HMDB

Chemical Formula

C₅H₁₀O₄

Average Molecular Weight

134.1305

Monoisotopic Molecular Weight

134.057908808

IUPAC Name

(2R)-2,3-dihydroxy-3-methylbutanoic acid

Traditional Name

(R)-2,3-dihydroxy-isovalerate

CAS Registry Number

19451-56-0

SMILES

CC(C)(O)[C@@H](O)C(O)=O

InChI Identifier

InChI=1S/C5H10O4/c1-5(2,9)3(6)4(7)8/h3,6,9H,1-2H3,(H,7,8)/t3-/m0/s1

InChI Key

JTEYKUFKXGDTEU-VKHMYHEASA-N

Chemical Taxonomy

Description

Belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group.

Kingdom

Organic compounds

Super Class

Lipids and lipid-like molecules

Class

Fatty Acyls

Sub Class

Fatty acids and conjugates

Direct Parent

Hydroxy fatty acids

Alternative Parents

Substituents

Branched fatty acid
Methyl-branched fatty acid
Short-chain hydroxy acid
Hydroxy fatty acid
Alpha-hydroxy acid
Hydroxy acid
Monosaccharide
Tertiary alcohol
1,2-diol
Secondary alcohol
Carboxylic acid derivative
Carboxylic acid
Monocarboxylic acid or derivatives
Organic oxygen compound
Carbonyl group
Hydrocarbon derivative
Organic oxide
Alcohol
Organooxygen compound
Aliphatic acyclic compound

Molecular Framework

Aliphatic acyclic compounds

External Descriptors

2,3-dihydroxy-3-methylbutanoic acid (CHEBI:15684 )

Ontology

Physiological effect

Adverse health effect

Renal system and urinary system

Renal disorder

Urinary tract disorder

Bladder cancer (PMID: 24023812 , PMID: 6321058 , PMID: 20971021 , +18

Source	Link
Pubmed	PMID: 24023812
Pubmed	PMID: 6321058
Pubmed	PMID: 20971021
Pubmed	PMID: 20573794
Pubmed	PMID: 23657156
Pubmed	PMID: 22800120
Pubmed	PMID: 21389975
Pubmed	PMID: 27012787
Pubmed	PMID: 9625050
Pubmed	PMID: 15740018
Pubmed	PMID: 12663291
Pubmed	PMID: 2702744
Pubmed	PMID: 16939360
Pubmed	PMID: 17474139
Pubmed	PMID: 15992788
Pubmed	PMID: 22827565
Pubmed	PMID: 22148915
Pubmed	PMID: 21388201
Pubmed	PMID: 22932811
Pubmed	PMID: 21799048
Pubmed	PMID: 28157703

)

Disposition

Biological location

Excreta

Feces
Urine

Non-excretory biofluid

Saliva

Horse

Lagomorphs

Ovis

Sheep (Mutton, Lamb)

Caprae

Domestic goat

Physical Properties

State

Solid

Experimental Molecular Properties

Property	Value	Reference
Melting Point	Not Available	Not Available
Boiling Point	Not Available	Not Available
Water Solubility	Not Available	Not Available
LogP	Not Available	Not Available

Experimental Chromatographic Properties

Not Available

Predicted Molecular Properties

Property	Value	Source
Water Solubility	529 g/L	ALOGPS
logP	-0.83	ALOGPS
logP	-0.82	ChemAxon
logS	0.6	ALOGPS
pKa (Strongest Acidic)	3.8	ChemAxon
pKa (Strongest Basic)	-3.2	ChemAxon
Physiological Charge	-1	ChemAxon
Hydrogen Acceptor Count	4	ChemAxon
Hydrogen Donor Count	3	ChemAxon
Polar Surface Area	77.76 Å²	ChemAxon
Rotatable Bond Count	2	ChemAxon
Refractivity	29.44 m³·mol⁻¹	ChemAxon
Polarizability	12.48 Å³	ChemAxon
Number of Rings	0	ChemAxon
Bioavailability	Yes	ChemAxon
Rule of Five	Yes	ChemAxon
Ghose Filter	No	ChemAxon
Veber's Rule	No	ChemAxon
MDDR-like Rule	No	ChemAxon

Predicted Chromatographic Properties

Predicted Collision Cross Sections

Predictor	Adduct Type	CCS Value (Å²)	Reference
DarkChem	[M+H]+	128.86	31661259
DarkChem	[M-H]-	124.232	31661259
DeepCCS	[M+H]+	126.726	30932474
DeepCCS	[M-H]-	122.897	30932474
DeepCCS	[M-2H]-	160.164	30932474
DeepCCS	[M+Na]+	135.6	30932474

Predicted Kovats Retention Indices

Underivatized

Metabolite	SMILES	Kovats RI Value	Column Type	Reference
(R)-2,3-Dihydroxy-isovalerate	CC(C)(O)[C@@H](O)C(O)=O	2348.5	Standard polar	33892256
(R)-2,3-Dihydroxy-isovalerate	CC(C)(O)[C@@H](O)C(O)=O	1070.2	Standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate	CC(C)(O)[C@@H](O)C(O)=O	1122.0	Semi standard non polar	33892256

Derivatized

Derivative Name / Structure	SMILES	Kovats RI Value	Column Type	Reference
(R)-2,3-Dihydroxy-isovalerate,1TMS,isomer #1	CC(C)(O[Si](C)(C)C)[C@@H](O)C(=O)O	1245.9	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,1TMS,isomer #2	CC(C)(O)[C@@H](O[Si](C)(C)C)C(=O)O	1252.4	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,1TMS,isomer #3	CC(C)(O)[C@@H](O)C(=O)O[Si](C)(C)C	1140.0	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,2TMS,isomer #1	CC(C)(O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C(=O)O	1328.4	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,2TMS,isomer #2	CC(C)(O[Si](C)(C)C)[C@@H](O)C(=O)O[Si](C)(C)C	1290.0	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,2TMS,isomer #3	CC(C)(O)[C@@H](O[Si](C)(C)C)C(=O)O[Si](C)(C)C	1250.7	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,3TMS,isomer #1	CC(C)(O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C(=O)O[Si](C)(C)C	1372.0	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,1TBDMS,isomer #1	CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O)C(=O)O	1517.1	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,1TBDMS,isomer #2	CC(C)(O)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O	1487.9	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,1TBDMS,isomer #3	CC(C)(O)[C@@H](O)C(=O)O[Si](C)(C)C(C)(C)C	1368.5	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,2TBDMS,isomer #1	CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O	1778.3	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,2TBDMS,isomer #2	CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O)C(=O)O[Si](C)(C)C(C)(C)C	1738.7	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,2TBDMS,isomer #3	CC(C)(O)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C	1714.2	Semi standard non polar	33892256
(R)-2,3-Dihydroxy-isovalerate,3TBDMS,isomer #1	CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C	2011.9	Semi standard non polar	33892256

Spectra

GC-MS Spectra

Spectrum Type	Description	Splash Key	Deposition Date	Source	View
Predicted GC-MS	Predicted GC-MS Spectrum - (R)-2,3-Dihydroxy-isovalerate GC-MS (Non-derivatized) - 70eV, Positive	splash10-0a4i-9000000000-59e6990530d950227520	2016-09-22	Wishart Lab	View Spectrum
Predicted GC-MS	Predicted GC-MS Spectrum - (R)-2,3-Dihydroxy-isovalerate GC-MS (3 TMS) - 70eV, Positive	splash10-00s9-9473000000-9708bfc20ee5ae043678	2017-10-06	Wishart Lab	View Spectrum
Predicted GC-MS	Predicted GC-MS Spectrum - (R)-2,3-Dihydroxy-isovalerate GC-MS (Non-derivatized) - 70eV, Positive	Not Available	2021-10-12	Wishart Lab	View Spectrum

MS/MS Spectra

Spectrum Type	Description	Splash Key	Deposition Date	Source	View
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 10V, Positive-QTOF	splash10-00kr-4900000000-196ffbbf313a33f24f27	2015-09-14	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 20V, Positive-QTOF	splash10-00ri-9300000000-aebebbbe2c7c11465a67	2015-09-14	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 40V, Positive-QTOF	splash10-0006-9000000000-92af6a04d8cb7601ab35	2015-09-14	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 10V, Negative-QTOF	splash10-0019-9500000000-2837622949a6bd688094	2015-09-15	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 20V, Negative-QTOF	splash10-00s9-9400000000-0fc7aa81197fc5feb444	2015-09-15	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 40V, Negative-QTOF	splash10-00dr-9000000000-45f3b95b2f30ea8445c1	2015-09-15	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 10V, Negative-QTOF	splash10-001i-2900000000-fab4ee9aeca7067a9207	2021-09-22	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 20V, Negative-QTOF	splash10-056r-9100000000-b3da44872fd12f996ec6	2021-09-22	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 40V, Negative-QTOF	splash10-05fr-9000000000-571b504e001a1456ab10	2021-09-22	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 10V, Positive-QTOF	splash10-00kr-9600000000-e4a123bb359dea0126e3	2021-09-22	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 20V, Positive-QTOF	splash10-05g0-9000000000-30fdda4eee690af3ee50	2021-09-22	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (R)-2,3-Dihydroxy-isovalerate 40V, Positive-QTOF	splash10-0006-9000000000-285f7931bf8163b701da	2021-09-22	Wishart Lab	View Spectrum

NMR Spectra

Spectrum Type	Description	Deposition Date	Source	View
Predicted 1D NMR	¹H NMR Spectrum (1D, 100 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 100 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 1000 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 1000 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 200 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 200 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 300 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 300 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 400 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 400 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 500 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 500 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 600 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 600 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 700 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 700 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 800 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 800 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 900 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 900 MHz, D₂O, predicted)	2021-09-29	Wishart Lab	View Spectrum

Biological Properties

Cellular Locations

Not Available

Biospecimen Locations

Feces
Saliva
Urine

Tissue Locations

Not Available

Pathways

Not Available

Name	SMPDB/PathBank	KEGG

Normal Concentrations

Biospecimen	Status	Value	Age	Sex	Condition	Reference	Details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Normal	29808030	details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Normal	27543620	details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Normal	25037050	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Normal	22308371	details
Urine	Detected and Quantified	<25 umol/mmol creatinine	Not Specified	Not Specified	Normal	26163321	details

Abnormal Concentrations

Biospecimen	Status	Value	Age	Sex	Condition	Reference	Details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Colorectal cancer	25037050	details
Feces	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Metastatic melanoma	28923537	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Attachment loss	31026179	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Missing teeth	31026179	details
Saliva	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Male	Periodontal Probing Depth	31026179	details
Urine	Detected but not Quantified	Not Quantified	Adult (>18 years old)	Both	Bladder cancer	28157703	details
Urine	Detected and Quantified	782-2500 umol/mmol creatinine	Infant (0-1 year old)	Both	Short-chain enoyl-CoA hydratase deficiency	26163321	details
Urine	Detected and Quantified	27-406 umol/mmol creatinine	Not Specified	Not Specified	Methylmalonyl-CoA mutase deficiency	26163321	details
Urine	Detected and Quantified	82-187 umol/mmol creatinine	Not Specified	Not Specified	Propionic acidemia	26163321	details
Urine	Detected and Quantified	566-704 umol/mmol creatinine	Children (1-13 years old)	Female	3-Hydroxyisobutyryl-coa hydrolase deficiency	26163321	details
Urine	Detected and Quantified	638 umol/mmol creatinine	Not Specified	Not Specified	Cobalamin A disease	26163321	details
Urine	Detected and Quantified	33 umol/mmol creatinine	Not Specified	Not Specified	Cobalamin C disease	26163321	details

Associated Disorders and Diseases

Disease References

Metastatic melanoma
Frankel AE, Coughlin LA, Kim J, Froehlich TW, Xie Y, Frenkel EP, Koh AY: Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 2017 Oct;19(10):848-855. doi: 10.1016/j.neo.2017.08.004. Epub 2017 Sep 15. [PubMed:28923537 ]
Colorectal cancer
Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Attachment loss
Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
Missing teeth
Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
Periodontal Probing Depth
Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
Methylmalonyl-CoA mutase deficiency
Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]
3-Hydroxyisobutyryl-coa hydrolase deficiency
Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]
Cobalamin A disease
Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]
Methylmalonic aciduria and homocystinuria, cblC type
Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]

Associated OMIM IDs

114500 (Colorectal cancer)
250620 (3-Hydroxyisobutyryl-coa hydrolase deficiency)
277400 (Methylmalonic aciduria and homocystinuria, cblC type)

External Links

DrugBank ID

Not Available

Phenol Explorer Compound ID

Not Available

FooDB ID

FDB028799

KNApSAcK ID

Not Available

Chemspider ID

389255

KEGG Compound ID

C04272

BioCyc ID

CPD-13357

BiGG ID

Not Available

Wikipedia Link

Not Available

METLIN ID

Not Available

PubChem Compound

440279

PDB ID

Not Available

ChEBI ID

15684

Food Biomarker Ontology

Not Available

VMH ID

23DHMB

MarkerDB ID

Not Available

Good Scents ID

Not Available

References

Synthesis Reference

Not Available

Material Safety Data Sheet (MSDS)

Not Available

General References

Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.

Showing metabocard for (R)-2,3-Dihydroxy-isovalerate (HMDB0012141)

MOL for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

3D MOL for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

3D SDF for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

3D-SDF for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

PDB for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

3D PDB for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

SMILES for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

INCHI for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

Structure for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

3D Structure for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

Predicted Collision Cross Sections

Predicted Kovats Retention Indices

Underivatized

Derivatized

GC-MS Spectra

MS/MS Spectra

NMR Spectra